surmount-1 tirzepatide weight loss non-diabetic Gastrointestinal tolerability and reduction associated with in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT‐1 to ‐4 trials - Rubino - 2025 💊 Could a new medication

Chromium (83% DV) Chromium is an essential part of the glucose tolerance factor (GTF) and is vital in regulating carbohydrate metabolism

In 2025, the brand aims to solidify its reputation as the regions leading skin ingredient expertleveraging tools like Revieves Skin Analyzer to showcase technological credibility and skincare authority

74% achieved HbA1c 6.5%

Direct Inhibition of Androgen Synthesis : Berberine reduces androgen production at the ovarian level, counteracting the hyperandrogenism characteristic of PCOS

23,24 These results emphasize the chronicity of obesity and the need for treatments that can maintain and maximize weight loss

2 Department of Geriatric Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Peoples Republic of China